THE PHARMACOLOGIC TREATMENT OF SCHIZOPHRENIA - A PROGRESS REPORT

被引：49

作者：

DONALDSON, SR

GELENBERG, AJ

BALDESSARINI, RJ

机构：

[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

[2] MASSACHUSETTS GEN HOSP, SPECIAL STUDIES CLIN, BOSTON, MA 02114 USA

[3] ERICH LINDEMANN MENTAL HLTH CTR, BOSTON, MA 02114 USA

[4] MCLEAN HOSP, MAILMAN RES CTR, PSYCHIAT RES LABS, BELMONT, MA 02178 USA

来源：

关键词：

D O I：

10.1093/schbul/9.4.504

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：504 / 527

页数：24

共 114 条

[1] ALEXANDER PE, 1979, AM J PSYCHIAT, V136, P283
[2] American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd
[3] LITHIUM PROPHYLAXIS IN RECURRENT AFFECTIVE DISORDERS
ANGST, J
WEIS, P
GROF, P
BAASTRUP, PC
SCHOU, M
[J]. BRITISH JOURNAL OF PSYCHIATRY, 1970, 116 (535) : 604 - +
[4] APPLETON WS, 1980, PRACTICAL CLIN PSYCH, P27
[5] FURTHER STUDIES WITH PROPRANOLOL IN PSYCHOTIC PATIENTS - RELATION TO INITIAL PSYCHIATRIC STATE, URINARY CATECHOLAMINES AND 3-METHOXY-4-HYDROXYPHENYLGLYCOL EXCRETION
ATSMON, A
BLUM, I
LATZ, A
STEINER, M
WIJSENBEEK, H
[J]. PSYCHOPHARMACOLOGIA, 1972, 27 (03): : 249 - +
[6] ATSMON A, 1976, ADV CLIN PHARMACOL, V12, P86
[7] BALDESSARINI RJ, 1979, AM J PSYCHIAT, V136, P1177
[8] WHAT IS THE BEST MAINTENANCE DOSE OF NEUROLEPTICS IN SCHIZOPHRENIA
BALDESSARINI, RJ
DAVIS, JM
[J]. PSYCHIATRY RESEARCH, 1980, 3 (02) : 115 - 122
[9] BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569
[10] BALDESSARINI RJ, CHEMOTHERAPY PSYCHIA